Preventive blood thinning drugs linked to reduced risk of death in COVID-19 patients

Patients given preventive blood thinning drugs (prophylactic anticoagulants) within 24 hours of admission to hospital with COVID-19 are less likely to die compared with those who do not receive them, a new study finds.

source https://www.sciencedaily.com/releases/2021/02/210211195328.htm